Ritonavir Impurity 34 | CAS 80232-90-2 - Request Quote
Ritonavir Impurity 34
| SZ CAT No: | SZ-R003079 |
| CAS No | 80232-90-2 |
| Mol.F. | C7H12N2S |
| Mol.Wt. | 156.2 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Ritonavir Impurity 34 is chemically 4-Isopropyl-N-methylthiazol-2-amine. Ritonavir Impurity 34 is supplied with detailed characterization data compliant with regulatory guideline. Ritonavir Impurity 34 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Ritonavir.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 80232-90-2
Purchase 80232-90-2
Order 80232-90-2
Enquire 80232-90-2
price of 80232-90-2
80232-90-2 Supplier
80232-90-2 Manufacturer
80232-90-2 Exporter
buy high quality Ritonavir Impurity 34
Purchase Ritonavir Impurity 34
Ritonavir Impurity 34 suppliers
Ritonavir Impurity 34 manufacturers
Ritonavir Impurity 34 price
Order Ritonavir Impurity 34
Enquire Ritonavir Impurity 34
Ritonavir Impurity 34 cost
Ritonavir Impurity 34 Supplier
Ritonavir Impurity 34 Distributor
Ritonavir Impurity 34 for Method Validation
Ritonavir Reference Standard
Ritonavir Impurity 34 for ANDA Filing
Ritonavir Impurity 34 for Forced Degradation Studies
Ritonavir Impurity 34 Identification Standards
Ritonavir Impurity 34 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


